Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:11102903rdf:typepubmed:Citationlld:pubmed
pubmed-article:11102903lifeskim:mentionsumls-concept:C0026845lld:lifeskim
pubmed-article:11102903lifeskim:mentionsumls-concept:C0037925lld:lifeskim
pubmed-article:11102903lifeskim:mentionsumls-concept:C0027740lld:lifeskim
pubmed-article:11102903lifeskim:mentionsumls-concept:C0030472lld:lifeskim
pubmed-article:11102903pubmed:issue12lld:pubmed
pubmed-article:11102903pubmed:dateCreated2000-12-12lld:pubmed
pubmed-article:11102903pubmed:abstractTextCancer can affect the peripheral nervous system by non-metastatic, sometimes immune-mediated mechanisms. Recognition of these paraneoplastic syndromes is important because it can lead to the detection of the tumor, and also helps to avoid unnecessary studies to determine the cause of the neurologic symptoms in patients with cancer. Many paraneoplastic syndromes of the peripheral nervous system are not associated with serum antibodies that serve as markers of paraneoplasia. For this group of disorders the diagnosis depends on the clinician's index of suspicion and conventional electrophysiologic and laboratory tests. Treatment of the tumor, immunotherapy, or both may improve some of these syndromes. This review focuses on paraneoplastic syndromes of the spinal cord, peripheral nerve, and muscle.lld:pubmed
pubmed-article:11102903pubmed:languageenglld:pubmed
pubmed-article:11102903pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11102903pubmed:citationSubsetIMlld:pubmed
pubmed-article:11102903pubmed:statusMEDLINElld:pubmed
pubmed-article:11102903pubmed:monthDeclld:pubmed
pubmed-article:11102903pubmed:issn0148-639Xlld:pubmed
pubmed-article:11102903pubmed:authorpubmed-author:DalmasHHlld:pubmed
pubmed-article:11102903pubmed:authorpubmed-author:RudnickiS ASAlld:pubmed
pubmed-article:11102903pubmed:copyrightInfoCopyright 2000 John Wiley & Sons, Inc.lld:pubmed
pubmed-article:11102903pubmed:issnTypePrintlld:pubmed
pubmed-article:11102903pubmed:volume23lld:pubmed
pubmed-article:11102903pubmed:ownerNLMlld:pubmed
pubmed-article:11102903pubmed:authorsCompleteYlld:pubmed
pubmed-article:11102903pubmed:pagination1800-18lld:pubmed
pubmed-article:11102903pubmed:dateRevised2004-11-17lld:pubmed
pubmed-article:11102903pubmed:meshHeadingpubmed-meshheading:11102903...lld:pubmed
pubmed-article:11102903pubmed:meshHeadingpubmed-meshheading:11102903...lld:pubmed
pubmed-article:11102903pubmed:meshHeadingpubmed-meshheading:11102903...lld:pubmed
pubmed-article:11102903pubmed:meshHeadingpubmed-meshheading:11102903...lld:pubmed
pubmed-article:11102903pubmed:meshHeadingpubmed-meshheading:11102903...lld:pubmed
pubmed-article:11102903pubmed:meshHeadingpubmed-meshheading:11102903...lld:pubmed
pubmed-article:11102903pubmed:year2000lld:pubmed
pubmed-article:11102903pubmed:articleTitleParaneoplastic syndromes of the spinal cord, nerve, and muscle.lld:pubmed
pubmed-article:11102903pubmed:affiliationDepartment of Neurology, University of Arkansas for Medical Sciences, 4301 West Markham, Slot 500, Little Rock, Arkansas 72205, USA.lld:pubmed
pubmed-article:11102903pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:11102903pubmed:publicationTypeReviewlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11102903lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11102903lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11102903lld:pubmed